EUVIMEDEUVIMED entdecken
Crossref

IGFBP1 stabilizes Umod expression through m6A modification to inhibit the occurrence and development of cystitis by blocking NF-κB and ERK signaling pathways

Zuliang Yuan, Wenjing Wang, Shuang Song, Yuntao Ling, Jing Xu, Zhen Tao

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.111997 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Zuliang Yuan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Nanjing First Hospital, Nanjing Medical University, Nanjing 210000, PR China. Hauptthemen laut MEDLINE: Cystitis, Insulin-Like Growth Factor Binding Protein 1, MAP Kinase Signaling System, NF-kappa B. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 77 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystitis is a common disease closely associated with urinary tract infections, and the specific mechanisms underlying its occurrence and development remain largely unknown. In this study, we discovered that IGFBP1 suppresses the occurrence and development of cystitis by stabilizing the expression of Umod through m6A modification, inhibiting the NF-κB and ERK signaling pathways. Initially, we obtained a bladder cystitis-related transcriptome dataset from the GEO database and identified the characteristic genes Umod and IGFBP1. Further exploration revealed that IGFBP1 in primary cells of cystitis can stabilize the expression of Umod through m6A modification. Overexpression of both IGFBP1 and Umod significantly inhibited cell apoptosis and the NF-κB and ERK signaling pathways, ultimately suppressing the production of pro-inflammatory factors. Finally, using a rat model of cystitis, we demonstrated that overexpression of IGFBP1 stabilizes the expression of Umod, inhibits the NF-κB and ERK signaling pathways, reduces the production of pro-inflammatory factors, and thus prevents the occurrence and development of cystitis. Our study elucidates the crucial role of IGFBP1 and Umod in cystitis and reveals the molecular mechanisms that inhibit the occurrence and development of cystitis. This research holds promise for offering new insights into the treatment of cystitis in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CystitisInsulin-Like Growth Factor Binding Protein 1MAP Kinase Signaling SystemNF-kappa BRats, Sprague-DawleyAnimalsFemaleHumansRatsApoptosisDisease Models, AnimalUrinary Bladder

Stichwörter der Autor:innen

CystitisERK signaling pathwayIGFBP1NF-κB signaling pathwayUmodm6A modification

Substanzen

Insulin-Like Growth Factor Binding Protein 1NF-kappa BIGFBP1 protein, human

Autor:innen und Institutionen

  • Department of Infectious Disease, Nanjing First Hospital, Nanjing Medical University, Nanjing 210000, PR China.
  • Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210000, PR China. Electronic address: xujing850408@163.com.
  • Department of Infectious Disease, Nanjing First Hospital, Nanjing Medical University, Nanjing 210000, PR China. Electronic address: tz1010@126.com.

Zitieren

APA

Yuan, Z., Wang, W., Song, S., Ling, Y., Xu, J., & Tao, Z. (2024). IGFBP1 stabilizes Umod expression through m6A modification to inhibit the occurrence and development of cystitis by blocking NF-κB and ERK signaling pathways. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.111997

Vancouver

Yuan Z, Wang W, Song S, Ling Y, Xu J, Tao Z. IGFBP1 stabilizes Umod expression through m6A modification to inhibit the occurrence and development of cystitis by blocking NF-κB and ERK signaling pathways. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.111997

BibTeX
@article{Yuan2024,
  author = {Yuan, Zuliang and Wang, Wenjing and Song, Shuang and Ling, Yuntao and Xu, Jing and Tao, Zhen},
  title = {IGFBP1 stabilizes Umod expression through m6A modification to inhibit the occurrence and development of cystitis by blocking NF-κB and ERK signaling pathways},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.111997}
}
Kostenlos starten →